These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2441029)

  • 1. Effect of morpholinyladriamycin analogs and adriamycin on the activities of DNA polymerase alpha and RNA polymerase II of chicken leukemia cells.
    Chuang LF; Chuang RY; Acton EM; Israel M; Yu M
    J Pharmacol Exp Ther; 1987 Jul; 242(1):372-7. PubMed ID: 2441029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro.
    Wassermann K; Zwelling LA; Mullins TD; Silberman LE; Andersson BS; Bakic M; Acton EM; Newman RA
    Cancer Res; 1986 Aug; 46(8):4041-6. PubMed ID: 3731072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic studies on N-benzyladriamycin-14-valerate (AD 198), a highly lipophilic alkyl adriamycin analog.
    Lameh J; Chuang LF; Israel M; Chuang RY
    Anticancer Res; 1988; 8(4):689-93. PubMed ID: 3052250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of eukaryotic RNA polymerase: a possible new mechanism of antitumor drug action.
    Chuang LF; Nooteboom GN; Israel M; Chuang RY
    Biochem Biophys Res Commun; 1984 May; 120(3):946-52. PubMed ID: 6375663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin in sensitive and resistant L5178Y lymphoblasts in vitro.
    Begleiter A; Leith MK; Johnston JB
    Cancer Res; 1994 Jan; 54(2):482-6. PubMed ID: 8275485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells.
    Traganos F; Israel M; Silber R; Seshadri R; Kirschenbaum S; Potmesil M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6273-9. PubMed ID: 4063977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cells.
    Streeter DG; Johl JS; Gordon GR; Peters JH
    Cancer Chemother Pharmacol; 1986; 16(3):247-52. PubMed ID: 3457646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of inhibition of DNA polymerases by 4'-epiadriamycin and 4'-O-tetrahydropyranyladriamycin.
    Tanaka M; Yoshida S; Kimura K
    Gan; 1983 Dec; 74(6):829-36. PubMed ID: 6365674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of N-trifluoroacetyladriamycin-14-O-hemiadipate with chicken leukemia RNA polymerase. Formation of drug-enzyme complex.
    Chuang RY; Chuang LF; Israel M
    Biochem Pharmacol; 1986 Apr; 35(8):1293-7. PubMed ID: 3754449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative cytotoxicities of various morpholinyl anthracyclines.
    Streeter DG; Taylor DL; Acton EM; Peters JH
    Cancer Chemother Pharmacol; 1985; 14(2):160-4. PubMed ID: 3971481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ; Wang H; Blair GW
    Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells.
    Momparler RL; Karon M; Siegel SE; Avila F
    Cancer Res; 1976 Aug; 36(8):2891-5. PubMed ID: 1277199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the initiation of leukemic transcription by N-trifluoroacetyladriamycin-14-O-hemiadipate in vitro. Impaired formation of RNA polymerase-DNA complex.
    Chuang LF; Israel M; Chuang RY
    J Biol Chem; 1984 Sep; 259(18):11391-5. PubMed ID: 6206068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of three second-generation anthracyclines with polynucleotides, RNA, DNA, and nucleosomes.
    Pearlman LF; Chuang RY; Israel M; Simpkins H
    Cancer Res; 1986 Jan; 46(1):341-6. PubMed ID: 2415249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation by adriamycin, daunomycin, verapamil, and trifluoperazine of the biochemical processes linked to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Satyamoorthy K; Perchellet JP
    Cancer Res; 1989 Oct; 49(19):5364-70. PubMed ID: 2475247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of chicken myeloblastosis RNA polymerase II activity by adriamycin.
    Chuang RY; Chuang LF
    Biochemistry; 1979 May; 18(10):2069-73. PubMed ID: 435465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.
    Satyamoorthy K; Deshpande SS; Chitnis MP
    Neoplasma; 1989; 36(6):673-83. PubMed ID: 2515459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of N-trifluoroacetyladriamycin-14-O-hemiadipate and radiation on L1210 cells.
    Potmesil M; Israel M; Kirschenbaum S; Bowen J; Silber R
    Radiat Res; 1986 Feb; 105(2):147-57. PubMed ID: 3754052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effects of daunomycin and adriamycin on various DNA polymerases.
    Zunino F; Gambetta R; Di Marco A; Zaccara A; Luoni G
    Cancer Res; 1975 Mar; 35(3):754-60. PubMed ID: 163690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin and the alkylating anthracycline 3'-deamino-3'-(3-cyano-4-morpholinyl) doxorubicin: comparative in vitro potency against leukemia and bone marrow cells.
    Beckman RA; McFall PJ; Sikic BI; Smith SD
    J Natl Cancer Inst; 1988 May; 80(5):361-5. PubMed ID: 3357201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.